140 related articles for article (PubMed ID: 38135213)
21. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11.
Bray B; Ramagopalan SV
J Comp Eff Res; 2023 May; 12(5):e230008. PubMed ID: 37052075
[TBL] [Abstract][Full Text] [Related]
22. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?
Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K
Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447
[TBL] [Abstract][Full Text] [Related]
23. COMPREHENSIVE ASSESSMENT OF COMPLEX TECHNOLOGIES: INTEGRATING VARIOUS ASPECTS IN HEALTH TECHNOLOGY ASSESSMENT.
Lysdahl KB; Mozygemba K; Burns J; Brönneke JB; Chilcott JB; Ward S; Hofmann B
Int J Technol Assess Health Care; 2017 Jan; 33(5):570-576. PubMed ID: 28780928
[TBL] [Abstract][Full Text] [Related]
24. Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?
Rosen EM; Ritchey ME; Girman CJ
Clin Ther; 2023 Dec; 45(12):1266-1276. PubMed ID: 37798219
[TBL] [Abstract][Full Text] [Related]
25. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 May; 11(7):473-475. PubMed ID: 35261285
[TBL] [Abstract][Full Text] [Related]
26. EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.
Liberati A; Sheldon TA; Banta HD
Int J Technol Assess Health Care; 1997; 13(2):186-219. PubMed ID: 9194352
[No Abstract] [Full Text] [Related]
27. Pragmatic versus explanatory trials.
MacRae KD
Int J Technol Assess Health Care; 1989; 5(3):333-9. PubMed ID: 10318324
[TBL] [Abstract][Full Text] [Related]
28. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 7.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jul; 11(10):699-701. PubMed ID: 35506497
[TBL] [Abstract][Full Text] [Related]
29. Health technology assessments and real-world evidence: tell us what you want, what you really, really want.
Griesinger F; Cox O; Sammon C; Ramagopalan SV; Popat S
J Comp Eff Res; 2022 Apr; 11(5):297-299. PubMed ID: 35212231
[No Abstract] [Full Text] [Related]
30. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Sep; 11(13):915-917. PubMed ID: 35703134
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness analyses using real-world data: an overview of the literature.
Bowrin K; Briere JB; Levy P; Millier A; Clay E; Toumi M
J Med Econ; 2019 Jun; 22(6):545-553. PubMed ID: 30816067
[No Abstract] [Full Text] [Related]
32. R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 4.
Simpson A; Ramagopalan SV
J Comp Eff Res; 2022 Jan; 11(1):11-12. PubMed ID: 34702048
[TBL] [Abstract][Full Text] [Related]
33. Alternative perspectives on the biased foundations of medical technology assessment.
Diamond GA; Denton TA
Ann Intern Med; 1993 Mar; 118(6):455-64. PubMed ID: 8439120
[TBL] [Abstract][Full Text] [Related]
34. Interactive technology assessment and wide reflective equilibrium.
Reuzel RP; van der Wilt GJ; ten Have HA; de Vries Robbé PF
J Med Philos; 2001 Jun; 26(3):245-61. PubMed ID: 11445880
[TBL] [Abstract][Full Text] [Related]
35. Practicalities of using a modified version of the Cochrane Collaboration risk of bias tool for randomised and non-randomised study designs applied in a health technology assessment setting.
Robertson C; Ramsay C; Gurung T; Mowatt G; Pickard R; Sharma P;
Res Synth Methods; 2014 Sep; 5(3):200-11. PubMed ID: 26052846
[TBL] [Abstract][Full Text] [Related]
36. HEALTH TECHNOLOGY ASSESSMENT OF PUBLIC HEALTH INTERVENTIONS: A SYNTHESIS OF METHODOLOGICAL GUIDANCE.
Mathes T; Antoine SL; Prengel P; Bühn S; Polus S; Pieper D
Int J Technol Assess Health Care; 2017 Jan; 33(2):135-146. PubMed ID: 28434414
[TBL] [Abstract][Full Text] [Related]
37. Methods in health service research. An introduction to bayesian methods in health technology assessment.
Spiegelhalter DJ; Myles JP; Jones DR; Abrams KR
BMJ; 1999 Aug; 319(7208):508-12. PubMed ID: 10454409
[No Abstract] [Full Text] [Related]
38. Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
Németh B; Kamusheva M; Mitkova Z; Petykó ZI; Zemplényi A; Dimitrova M; Tachkov K; Balkányi L; Czech M; Dawoud D; Goettsch W; Hren R; Knies S; Lorenzovici L; Maravic Z; Piniazhko O; Zerovnik S; Kaló Z
J Comp Eff Res; 2023 Apr; 12(4):e220157. PubMed ID: 36861458
[No Abstract] [Full Text] [Related]
39. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
[TBL] [Abstract][Full Text] [Related]
40. Action research: a systematic review and guidance for assessment.
Waterman H; Tillen D; Dickson R; de Koning K
Health Technol Assess; 2001; 5(23):iii-157. PubMed ID: 11785749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
